New Zealand - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2012, New Zealand Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 4.6% year on year. In 2017, the country was ranked number 276 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 5 Cases. India topped the ranking with 66,255 Cases in 2019, an increase of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2017 | 5.00 |
| 2016 | |
| 2015 | |
| 2014 | 5.00 |
| 2013 | 3.00 |
Download all data from 2005 to 2017
How does New Zealand rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 274 |
#274
Albania
|
6 | 2019 | +50.0 % | +14.9 % | View data | |
| 276 |
#276
New Zealand
|
5 | 2017 | NA | +4.6 % | View data | |
| 276 |
#276
Oman
|
5 | 2019 | +0.0 % | -9.0 % | View data | |